Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Technical Analysis

212 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is 2.43, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 52.12, while Keros Therapeutics’s (KROS) share price is $57.32, making it a Buy.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 50.03, while Keros Therapeutics’s (KROS) share price is $57.32, making it a Buy.

Keros Therapeutics (KROS) Pivot Points

Sep 19, 2024, 10:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.40
54.00
54.52
55.12
55.64
56.24
56.76
Fibonacci
54.00
54.43
54.69
55.12
55.55
55.81
56.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Sep 19, 2024, 10:27 PM
Period
Simple
Exponential
MA5
55.95Sell
55.43Buy
MA10
54.93Buy
54.26Buy
MA20
50.68Buy
52.12Buy
MA50
49.09Buy
50.03Buy
MA100
49.54Buy
49.89Buy
MA200
52.02Buy
48.15Buy
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 54.26, while Keros Therapeutics’s (KROS) share price is $57.32, making it a Buy.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 49.89, while Keros Therapeutics’s (KROS) share price is $57.32, making it a Buy.
Keros Therapeutics’s (KROS) stock price is $57.32 and Keros Therapeutics’s (KROS) 50-day simple moving average is 49.09, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $57.32 and Keros Therapeutics’s (KROS) 100-day simple moving average is 49.54, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $57.32 and Keros Therapeutics’s (KROS) 200-day simple moving average is 52.02, creating a Buy signal.

Keros Therapeutics (KROS) Technical Indicators

Sep 19, 2024, 10:27 PM
Name
Value
Implied Action
RSI (14)
66.26
Neutral
STOCH (9,6)
61.25
Neutral
STOCHRSI (14)
78.79
Neutral
MACD (12,26)
2.43
Sell
ADX (14)
32.65
Neutral
Williams %R
-19.62
Sell
CCI (14)
77.87
Neutral
ATR (14)
2.46
-
Ultimate Oscillator
52.83
Neutral
ROC
23.64
Buy
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 66.26, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 32.65, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is 77.87, creating a Neutral signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is 23.64, creating a Buy signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Buy.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 66.26, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is 2.43, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 55.95, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 50.68, which suggests KROS is a Buy.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 49.09, which suggests KROS is a Buy.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 52.02, which suggests KROS is a Buy.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -19.62, which suggests KROS is a Sell.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is 77.87, which suggests KROS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis